NO20002830L - Langtidsvirkende, injiserbare formuleringer inneholdende hydrogenert lakserolje - Google Patents

Langtidsvirkende, injiserbare formuleringer inneholdende hydrogenert lakserolje

Info

Publication number
NO20002830L
NO20002830L NO20002830A NO20002830A NO20002830L NO 20002830 L NO20002830 L NO 20002830L NO 20002830 A NO20002830 A NO 20002830A NO 20002830 A NO20002830 A NO 20002830A NO 20002830 L NO20002830 L NO 20002830L
Authority
NO
Norway
Prior art keywords
castor oil
hydrogenated castor
formulations containing
long acting
injectable formulations
Prior art date
Application number
NO20002830A
Other languages
English (en)
Other versions
NO20002830D0 (no
NO329469B1 (no
Inventor
James B Williams
Rey T Chern
Original Assignee
Merck & Co Inc
Merial Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20002830(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9809792.6A external-priority patent/GB9809792D0/en
Application filed by Merck & Co Inc, Merial Llc filed Critical Merck & Co Inc
Publication of NO20002830D0 publication Critical patent/NO20002830D0/no
Publication of NO20002830L publication Critical patent/NO20002830L/no
Publication of NO329469B1 publication Critical patent/NO329469B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002830A 1997-12-03 2000-06-02 Langtidsvirkende, injiserbare formuleringer inneholdende hydrogenert lakserolje NO329469B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6737497P 1997-12-03 1997-12-03
GBGB9809792.6A GB9809792D0 (en) 1998-05-07 1998-05-07 Long acting injectable formulations containing hydrogenated castor oil
PCT/US1998/019016 WO1999027906A1 (en) 1997-12-03 1998-09-14 Long acting injectable formulations containing hydrogenated castor oil

Publications (3)

Publication Number Publication Date
NO20002830D0 NO20002830D0 (no) 2000-06-02
NO20002830L true NO20002830L (no) 2000-08-03
NO329469B1 NO329469B1 (no) 2010-10-25

Family

ID=26313620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002830A NO329469B1 (no) 1997-12-03 2000-06-02 Langtidsvirkende, injiserbare formuleringer inneholdende hydrogenert lakserolje

Country Status (27)

Country Link
EP (1) EP1035835B1 (no)
JP (1) JP3925900B2 (no)
KR (1) KR100499438B1 (no)
CN (1) CN1205921C (no)
AR (1) AR017779A1 (no)
AT (1) ATE249206T1 (no)
AU (1) AU749006B2 (no)
BG (1) BG65147B1 (no)
BR (1) BR9815352A (no)
CA (1) CA2312898C (no)
CO (1) CO4970836A1 (no)
DE (1) DE69818093T2 (no)
DK (1) DK1035835T3 (no)
EA (1) EA002497B1 (no)
ES (1) ES2205550T3 (no)
HR (1) HRP20000366B1 (no)
HU (1) HU228617B1 (no)
IL (1) IL136313A (no)
ME (1) ME00855B (no)
NO (1) NO329469B1 (no)
NZ (1) NZ504783A (no)
PL (1) PL192651B1 (no)
PT (1) PT1035835E (no)
RS (1) RS49838B (no)
SK (1) SK284522B6 (no)
TW (1) TW550088B (no)
WO (1) WO1999027906A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6538031B1 (en) * 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
JP4502641B2 (ja) * 2002-01-24 2010-07-14 ティルタン ファーマ リミテッド 抗癌組み合わせおよびその使用方法
CN1275589C (zh) * 2002-05-31 2006-09-20 王玉万 含抗寄生虫药物的缓释注射剂
UY27412A1 (es) * 2002-08-12 2003-06-30 Carlson Internat Inc Un nuevo producto para el combate de garrapatas y el proceso para la prepaacinn.
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004045581A1 (fr) * 2002-11-18 2004-06-03 Yuwan Wang Injection d'une suspension d'un antiparasite veterinaire
AU2003284802A1 (en) * 2002-11-27 2004-06-18 Eco Animal Health Ltd An injection of animal remedy including closantel or closantel sodium
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
KR100717433B1 (ko) * 2003-03-20 2007-05-14 파마시아 코포레이션 소염제의 분산성 배합물
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
CN1293921C (zh) * 2003-08-18 2007-01-10 王玉万 含乙基纤维素和脂肪酸酯类的长效注射剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2005084688A1 (en) * 2004-03-04 2005-09-15 Yuwan Wang An injection power containing vermifuge
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
RU2283590C1 (ru) * 2005-05-14 2006-09-20 ООО "Астрафарм" Инсектоакарицидный состав для млекопитающего
DE102006043444A1 (de) * 2006-09-15 2008-03-27 Bayer Cropscience Ag Suspensionskonzentrate auf Ölbasis
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
GB0804619D0 (en) * 2008-03-12 2008-04-16 Norbrook Lab Ltd A topical ectoparasiticide composition
US8450357B2 (en) * 2008-11-19 2013-05-28 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
US20150238446A1 (en) * 2012-07-27 2015-08-27 Novartis Ag New treatment of fish with a nanosus pens ion of lufenuron or hexaflumuron
US20150297565A1 (en) * 2012-12-12 2015-10-22 Zoetis Services Llc Phenylpyrazole injectable compositions
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN104337761B (zh) * 2013-08-07 2019-03-26 江苏豪森药业集团有限公司 氟维司群药物组合物
EP3082762B1 (en) * 2013-12-16 2021-11-17 Zoetis Services LLC Long-acting ketoprofen compositions
CN103721266A (zh) * 2014-01-06 2014-04-16 王玉万 含阿维菌素类药物/氢化蓖麻油的原位胶凝注射剂
WO2016201259A1 (en) 2015-06-10 2016-12-15 Piedmont Pharmaceuticals Llc Injectable antibiotic formulations and use thereof
WO2020223959A1 (en) * 2019-05-09 2020-11-12 The Procter & Gamble Company Stable anti-mite liquid laundry detergent composition comprising benzyl benzoate
JP7752051B2 (ja) * 2019-05-24 2025-10-09 デクラ ベテリナリー プロダクツ リミテッド ライアビリティー カンパニー 長時間作用型注射用製剤およびその使用
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1060632A (en) * 1962-09-11 1967-03-08 Olin Mathieson Steroid compositions
DE2548413A1 (de) * 1975-10-27 1977-04-28 Schering Ag Depotpraeparate in oeliger ungesaettigter loesung zur intramuskulaeren injektion
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US4427663A (en) * 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
EP0237482A1 (de) * 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
DE3785936T2 (de) * 1986-03-25 1993-08-26 Sankyo Co Makrolid-derivate, ihre herstellung und ihre verwendung.
EP0252879B1 (de) * 1986-07-02 1992-05-06 Ciba-Geigy Ag Pestizide
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) * 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) * 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
DE69229318T2 (de) * 1991-09-30 1999-11-18 Merck & Co Inc Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
DE69636706T2 (de) * 1995-09-25 2007-10-11 Ashmont Holdings Ltd., Takapuna Makrocyclische lacton anthelmintika
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl

Also Published As

Publication number Publication date
HK1032917A1 (en) 2001-08-10
HUP0100606A2 (hu) 2001-06-28
IL136313A0 (en) 2001-05-20
KR20010032760A (ko) 2001-04-25
PT1035835E (pt) 2003-12-31
JP3925900B2 (ja) 2007-06-06
DE69818093D1 (de) 2003-10-16
BG104560A (en) 2001-04-30
EA002497B1 (ru) 2002-06-27
CN1205921C (zh) 2005-06-15
ATE249206T1 (de) 2003-09-15
WO1999027906A1 (en) 1999-06-10
TW550088B (en) 2003-09-01
EP1035835A1 (en) 2000-09-20
RS49838B (sr) 2008-08-07
CA2312898C (en) 2004-05-11
NO20002830D0 (no) 2000-06-02
BR9815352A (pt) 2000-10-17
IL136313A (en) 2005-08-31
SK8292000A3 (en) 2000-11-07
HU228617B1 (en) 2013-04-29
HUP0100606A3 (en) 2002-11-28
AU9385898A (en) 1999-06-16
ES2205550T3 (es) 2004-05-01
JP2001524510A (ja) 2001-12-04
PL192651B1 (pl) 2006-11-30
CO4970836A1 (es) 2000-11-07
ME00855B (me) 2008-08-07
SK284522B6 (sk) 2005-05-05
AU749006B2 (en) 2002-06-13
CN1283990A (zh) 2001-02-14
HRP20000366A2 (en) 2001-06-30
EP1035835B1 (en) 2003-09-10
AR017779A1 (es) 2001-10-24
NZ504783A (en) 2002-12-20
YU34500A (sh) 2002-11-15
CA2312898A1 (en) 1999-06-10
EA200000604A1 (ru) 2000-12-25
DK1035835T3 (da) 2003-12-08
PL341542A1 (en) 2001-04-23
BG65147B1 (bg) 2007-04-30
KR100499438B1 (ko) 2005-07-07
HRP20000366B1 (en) 2009-08-31
NO329469B1 (no) 2010-10-25
DE69818093T2 (de) 2004-06-09

Similar Documents

Publication Publication Date Title
NO20002830L (no) Langtidsvirkende, injiserbare formuleringer inneholdende hydrogenert lakserolje
PT1283051E (pt) Formulacoes de insulina estaveis
DE69826127D1 (de) 2-substituierte 4,5-diarylimidazole
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
TR199800375A3 (tr) Selant kompozisyonlari.
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
TR199901077A3 (tr) Ispençiyari formülasyonlar.
BR9805993B1 (pt) composição farmacêutica de aerossol.
DE69707887D1 (de) Antitranspirant/deodorant flüssige zusammensetzung
DE69826138D1 (de) Parfümzusammensetzung
DE69705474D1 (de) Hydraulikreservoir
DE69801318D1 (de) Verbesserte ölzusammensetzungen
TR199501082A2 (tr) Farmasötik formülasyonlar.
NL1002451A1 (nl) Sluitdop.
TR199700147A2 (tr) Mikrop öldürücü terkip.
DE69828708D1 (de) Deodorant-zusammensetzung
IT242987Y1 (it) Guarnitura per mobili.
FI943069A0 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
IT246279Y1 (it) Guarnitura per mobili
FI961364L (fi) Lääkeainekoostumus
TR199700155A2 (tr) Mikrop öldürücü terkip.
BR9804596B1 (pt) composiÇço cosmÉtica bifÁsica.
ZA9810975B (en) Long acting injectable formulations containing hydrogenated castor oil
SI1035835T1 (en) Long acting injectable formulations containing hydrogenated castor oil
GB9809792D0 (en) Long acting injectable formulations containing hydrogenated castor oil

Legal Events

Date Code Title Description
MK1K Patent expired